Author:
Orellana-Westermeyer Vicente,Arellano Javier,Gallego Consuelo
Reference10 articles.
1. Current perspectives on Stevens-Johnson syndrome and toxic epidermal necrolysis;Lerch;Clin Rev Allergy Immunol,2018
2. Infantile Stevens Johnson syndrome and toxic epidermal necrolysis: a systematic review of clinical features and outcomes in children ages 12 months and under;Iriarte;Pediatr Dermatol,2022
3. Clinical features, outcomes and treatment in children with drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis;Iotti;Acta Biomed,2019
4. Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome;Jacobsen;Cochrane Database Syst Rev,2022
5. Biologic TNF-α inhibitors for Stevens-Johnson syndrome, toxic epidermal necrolysis, and TEN-SJS overlap: a study-level and patient-level meta-analysis;Cao;Dermatol Ther (Heidelb),2023